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Effet d'un bolus intraveineux de phénylephrine ou d'éphedrine sur le flux sanguin cutané 
lors d'une anesthésie rachidienne 
Introduction : La phénylephrine et i'éphedrine sont des substances vaso-actives utilisées de routine 
pour corriger des épisodes d'hypotension artérielle induits par l'anesthésie intrarachidienne. 
L'influence de ces deux vasopresseurs sur le flux sanguin cutané (FSC) dans ce contexte n'a jusqu'à 
maintenant pas été décrite. Cette étude évalue l'effet d'une injection intraveineuse de 75 µg de 
phénylephrine ou de 7.5 mg d'éphedrjne·sur le FSC mesuré par Laser Doppler, dans les zones 
concernées par le bloc sympathique induit par l'anesthésie intrarachidienne (membres inférieurs) et 
dans les zones non concernées (membres supérieurs). 
Méthode : Après acceptation par le Comité d'Ethique, et obtention de leur accord écrit, 20 patients 
devant subir une intervention chirurgicale élei::tive en décubitus dorsal sous anesthésie 
intrarachidienne ont été inclus dans cette étude randomisée en double insu. Le FSC a été mesuré en 
continu par deux sondes fixées l'une à la cuisse (zone avec bloc sympathique) et l'autre sur l'avant-
bras (zone sans bloc sympathique). Les valeurs de FSC ont été enregistrées après l'anesthésie 
rachidienne (valeur contrôle), puis après l'injection i.v. de phénylephrine (10 patients) ou d'éphedrine 
(10 patients) pour corriger une hypotension définie comme une chute de 20 mmHg de la pression 
artérielle systolique. Les variations de FSC exprimées en pourcentage de la valeur contrôle moyenne 
(+/-écart type) ont été analysées par le test t de Student. 
Résultats : Les données démographiques des patients et le niveau sensitif induit par l'anesthésie 
rachidienne sont similaires dans les deux groupes. Aux doses utilisées, seule l'éphedrine restaure la 
pression artérielle aux valeurs précédant l'anesthésie rachidienne. La phénylephrine augmente le FSC 
de l'avant-bras de 44% ( +/- 79%) et de la cuisse de 34% ( +/-24%), alors que l'éphedrine diminue le 
débit sanguin cutané de l'avant-bras de 16% (+/- 15%) et de la cuisse de 22% (+/-11%). 
Conclusion : L'injection intraveineuse de phénylephrine et d'éphedrine ont des effets opposés sur le 
flux sanguin cuFané, et cette réponse n'est pas modifiée par le bloc sympathique. Cette différence 
peut s'expliquer par la distribution des sous-types de récepteurs adrénergiques alpha et leur 
prédominance relative dans les veines et les artères de différents diamètres perfusant le tissu sous-
cutané et la peau. L'éphedrine, en raison de sa meilleure efficacité pour traiter les épisodes 
d'hypotension artérielle après anesthésie intrarachidienne devrait être préférer à la phénylephrine, 
leurs effets opposes sur le flux sanguin cutané n'étant pas pertinents en pratique clinique. 
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SUMMARY 
Background: Phenylephrine or ephedrine is routinely used to correct hypotensive episodes following 
spinal anaesthesia (SA). The influence of these two vasopressors on skin blood flow (SBF) has not yet 
been described. We have therefore evaluated the effects of an i.v. bolus of 75 µg phenylephrine or 
7.5 mg of ephedrine on SBF measured by laser Doppler flowmetry during sympathetic blockade 
induced by SA. 
Methods: With Ethical Committee approval and written consent, 20 patients scheduled for elective 
procedures in supine position under SA were enrolled in this double-blind randomized study. SBF was 
measured continuously by two probes fixed at the thigh (area with sympathie blockade) and forearm 
level (area without sympathie blockade) respectively. SBF values were recorded after SA (contrai 
values) and then after a bolus administration of phenylephrine (n=10) or ephedrine (n=10) when 
systolic blood pressure decreased by 20 mmHg. Changes were expressed as percentage of contrai 
SBF values and analysed by Student's paired t-test. 
Results: Patient characteristics and dermatomal sensory levels were similar in both groups. 
Phenylephrine increases mean SBF at the forearm level by 44% (79%) [mean (SD)] and at the thigh 
by 34% (24%). Ëphedrine decreases SBF at the forearm level by 16% (15%) and at the thigh by 22% 
( 11 % ). Ephedrine bolus restores arterial blood pressure to pre-anaesthesia values, whereas 
phenylephrine does not. 
Conclusion: Administration of phenylephrine and ephedrine has opposite effects on skin blood flow 
and sympathetic blockade does not modify this response. These findings could be explained by the 
distribution of the alpha-adrenoreceptor subtypes and their relative pred6minance among veins and 
arteries of different size perfusing the subcutaneous tissue and the skin. Ephedrine, due to its better 
efficacy to correct hypotensive episodes following SA, should be preferred to phenylephrine, their 
opposite effects on SBF being not relevant for clinical practice. 
Keywords: Anaesthetic techniques, regional, spinal 
Blood flow, skin 
Sympathetic nervous system, ephedrine 
Sympathetic nervous system, phenylephrine 
Measurement techniques, laser Doppler flowmetry 
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Introduction : 
Hypotension during spinal anaesthesia (SA) (1) , is a common complication which may have 
detrimentaL effects, particularly during caesarean delivery (2) or in the geriatric population (3). The 
administration of vasopressors associated with intravenous cristalloids preload to · counteract 
vasoplegia induced by spinal anaesthesia is widely accepted, but the choice of the best vasopressor 
remains a controversial tapie among anesthesiologists ( 4,5). Recent studies have indeed challenged 
the efficacy of prophylactic intravenous ephedrine given either in small bolus doses or by infusion 
during spinal anaesthesia for elective cesarean section (6). Several trials suggest also that 
phenylephrine may have similar efficacy to ephedrine for preventing and tre~ting hypotension during 
spinal anaesthesia (6,7). Moreover, it has been shown that the addition of phenylephrine to 
prophylactic ephedrine infusion halved the incidence of hypotension during SA for scheduled cesarean 
delivery (7). 
Ephedrine, a mixed alpha and beta-adrenergic agonist (8) has a .good track record in 'non-obstetric 
practice to treat bradycardia and hypotension, but in prophylactic use it could trigger episodes of 
marked hypertension and tachycardia ( 4,9). 
Phenylephrine, a pure alpha 1-adrenergic agonist ( 10), is effective also for treating hypotension 
induced by blockade of the sympathetic nervous system. It produces marked arterial vasoconstriction 
and subsequent bradycardia (8). 
While changes on skin blood flow (SBF) induced by sympathetic blockade have already been studied 
(11), the effects of these two vasopressors have not yet been described in the setting of spinal 
anaesthesia. This study was conducted to verify wether the vasoconstrictor effect of ephed~ine and 
phenylephrine on SBF is of same magnitude. 
Patients and Methods : 
After obtaining approval by the institutional Clinical Research Ethics Committee and written informed 
consent, twenty ASA status !-II adult patients scheduled for elective surgery under spinal anaes.thesia 
(SA) were enrolled in this prospective, randomized, double-blind study. Patients with neurologie 
disease, autonomie dysfunction, hypertension or under treatment with ~-blocking or vasoconstricting 
agents were excluded. Pregnant patients were not included. 
After an oral premedication with 7.5 mg midazolam one hour before surgery, standard monitoring 
devices were applied (Datex AS 3; Datex-Ohmeda ; Instrumentarium Corporation, Helsinki, Finlande), 
and an 18G venous canula was inserted in a large vein on the dorsum of the hand. An intravenous 
' . 
preload of 500 ml Lactated Ringer's solution was then started and a SA was performed at the L3-L4 or 
- 4 -
L4-L5 interspace with the patient in the late~al jack-knife position using a 9-cm 25 gauge Whitacre 
spinal needle. Once free flow of cerebrospinal fluid had been recognized, hyperbaric 0.5 % 
bupivacaine (12.5-15 mg) was injected intrathecally over 20 seconds. The patient was then placed in 
the supine position and arterial pressure measured by an automatic non-invasive monitor at intervals 
of one minute. Dermatomal sensory block was assessed with ether, ten, thirty and sixty minutes after 
completion of the spinal injection. If systolic blood pressure decreased by 20 mmHg from baseline, an 
i.v. bolus dose of ephedrine 7.5 mg or phenylephrine 75 µg was injected by the anaesthetist who was 
unaware of the vasopressor administered. This procedure was repeated if necessary. SBF. was 
assessed by a non-invasive dual-channel laser Doppler (Periflux PF-4001, Perimed, Stockholm, 
Sweden) flowmetry technique (12, 13). To eliminate blood flow changes induced by skin temperature 
variations (14), local warming was performed using special thermostatic probe holders (Peritemp 
4005, Perimed, Stockholm, Sweden) which were attached to the skin via a double-adhes.ive tape 
rings. One laser probe was positioned on the volar surface of one forearm and the second one in an 
area under SA blockade on the mid-internal upper part of the thigh. The continuous laser Doppler 
flowmeter signal expressing blood flow in arbitrary perfusion units (PU) was transferred on line to a 
computer and analyzed with the Perisoft software (Perimed, Stockholm, Sweden). Because of the 
instantaneous variability of the laser Doppler signal, mean SBF averaged during one minute was 
measured before SA (baseline value), twenty minutes after completion of SA then immediately before 
random vasopressor bolus injection and finally few minutes (at peak effect) after the first injection of 
the vasopressor. Cutaneous vascular conductance (CVC) was calculated as mean SBF divided by mean 
arterial pressure (MAP) obtained from the electrical integration of the pressure signal. 
Datas are expressed as mean (SD) unless stated otherwise. Demographic, haemodynamic and SBF 
characteristics of both groups were compared by using Fisher's exact test and unpaired Student's t-
test when appropriated. An analysis of variance for repeated measures in the same subjects followed 
by Bonferroni correction was used to detect differences within the two groups (15). 
Results: 
Patients characteristics and dermatomal sensory levels after SA were similar in both groups (Table 1). 
Likewise, hemodynamic variables, mean SBF measured before and twenty minutes after spinal 
anaesthesia in non glabrous skin areas of the forearm and the thigh, along with calculated cutaneous 
vascular conductance (CVC) and perfusion variation (LiP) are presented in table 2. 
Twenty minutes after SA, mean arterial pressure decreases significantly in both groups, whereas 
mean SBF and skin conductance increase in the forearm and in the upper thigh (table 2). 
After an i.v. bolus of phenylephrine 75 µg or ephedrine 7.5 mg, administered to treat an hypotensive 
episode, mean arterial pressure increases significantly (figure 1). Whereas ephedrine restore MAP to 
baseline value, phenylephrine does not (figure 1). At any time during the study (before SA, twenty 
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minutes after SA, before and after the administration of vasopressors), there were no differences in 
MAP between the two groups (Tables 2 and 3). 
SBF and conductance are increased by phenylephrine and decreased by ephedrine (table 3). These 
responses -albeit non significant- were similar and of same magnitude whether measured in skin 
areas under sympathetic blockade or not (table 3). Individual and mean variation of SBF triggered by 
both vasopressors are presented in figure 2 and table 3. When expressed in percentage, 
phenylephrine increase SBF in the upper and lower limbs by 44% (79%) and 34% (24%) respectively. 
After ephedrine injection, the decrease of SBF in the upper and lower limbs was 16% (15%) and 22% 
(11 %) respectively (table 3). When compared, SBF differences between ephedrine and phenylephrine 
injections are significant (p <0.05). 
Discussion: 
Our results show that an i.v. bolus of 75 µg of phenylephrine increase the SBF while 7.5 mg of 
ephedrine decreases the SBF. At these doses, ephedrine is more efficient than phenylephrine to treat 
-at least transiently- the drop of blood pressure induced by the sympathetic blockade. The effects of 
both vasopressors on SBF and skin vascular conductance are similar in both upper and lower limbs 
(Table 3). 
Despite the important interindividual variability, the decrease of SBF after ephedrine has been shown 
in ail but one patient, only in the superior limb (figure 2), and an increase in SBF in ail patients of the 
phenylephrine group. Our results therefore strongly suggest that phenylephrine induces an increase in 
SBF, and ephedrine induces a decrease of SBF. 
Before commenting our findings, the mechanisms of contrai of skin perfusion should be briefly 
discussed. Cutaneous circulation, which represents at rest a marginal part of the cardiac output (5-
6%), is complex and includes thermoregulatory and non-thermoregulatory reflex inputs to the central 
nervous system (CNS)(16). In humans, reflex contrai of the skin blood flow is mediated through two 
sympathetic efferent pathways: an adrenergic vasoconstrictor system with norepinephrine as 
transmitter, which acts on postsynaptic alpha-1 and alpha-2 adrenergic receptors (17,18). The second 
pathway is a non-adrenergic active vasodilator system by cholinergie nerve co-transmission through 
· release of an unknown transmitter (17). Other substances released by the vascular endothelium 
modulate also. arterial blood flow. Endothelin, a vasoconstrictor peptide, interferes with alpha-
adrenergic receptor (19), while prostacyclin and nitric oxide relax vascular smooth muscle (20, 21). 
The mechanisms of decrease in SBF induced by ephedrine can be explained by previous in-vitro 
studies. According to Nielsen and Borbujo, postjunctional alpha-2 adrenoreceptors are present in 
human subcutaneous resistance arteries, and are predominent over the alpha-1 adrenoreceptor 
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subtype (22,23). Preparations of human subcutaneous arteries indeed are more sensitive to clonidine, 
a predominantly alpha-2 adrenoreceptor agonist than to norepinephrine, a mixed alpha-1 and alpha-2 
adrenoreceptor agonist, and to phenylephrine, an alpha-1 adrenoreceptor agonist (23). In vivo 
confirmation is provided by Dinenno and colleagues, which concludes that vasoconstricting post-
junctional alpha-2 adrenoreceptors contribute more to basal vascular tone than alpha-1 
adrenoreceptors in the forearms of young healthy men (24). Ephedrine therefore, by its non-selective 
alpha-adrenoreceptor agonist property and its inhib.ition of norepinephrine re-uptake, is a patent 
subcutaneous arterial vasoconstrictor. A mixture of alpha-1 and alpha-2 adrenoreceptors have also 
been found in vein (25). Since ephedrine can increase the venous tone, it could indirectly contribute 
to the decrease in arterial skin blood flow. For these reasons and according to our results, the SBF 
decreases after the administration of ephedrine also in skin areas under sympathetic blockade. 
The increase in SBF induced by phenylephrine has been also shown in an animal model by Sanie et al, 
who investigated the effect of local and systemic injection of phenylephrine on muscular and skin 
blood flow in free musculocutaneous flaps (26, 27). In these investigations they also assess the flow 
variations in contrai territories, under the effects of an epidural anaesthesia or not. In bath studies 
systemic administration of phenylephrine increase mean skin blood flow by 9% and 16% respectively. 
other informations concerning the influence of muscle blood flow variations induced by vasopressors 
on skin blood flow are still lacking. 
We may consider two mechanisms, alone or in combination, that could explain these findings. 
Phenylephrine, a pure alphal-adrenergic agonist, is known to constrict mainly arterioles with a 
diameter larger than 110 µm (28). Because of its more prominent alpha-2 adrenoreceptors 
population; smaller skin arterioles do not respond to systemic infusion of phenylephrine (23). It should 
be mentioned however that SBF measured by laser-doppler flowmetry is not influenced by underlying 
skeletal muscle blood flow when vasodilation is triggered by mild muscular hyperhemia (29). We can 
therefore postulate that phenylephrine administration, by its vasoconstrictive effect, reduces muscle 
blood flow, creating thereby an "overflow" to the skin whose arterioles are less constricted. Such an · 
overflow could not be observed with ephedrine, which induces a stronger subcutaneous 
vasoconstriction. This hypothesis is only partly sustained by our datas since we did not measure 
muscular blood flow. 
The direct effects of epheddne or phenylephrine on venous tone could also contribute to modulate the 
SBF. Steen et al showed in isolated human groin vessels that phenylephrine was significantly more 
patent in arteries than in veins, whereas norepinephrine was more patent in veins than in arteries. 
These results suggest that there is a functional predominance of alpha 2-adrenoreceptors in the veins 
(30). These findings could explain why ephedrine, compared to phenylephrine, increases venous tone 
leading thereby to SBF reduction. 
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This study has several limitations. We used a single dosage of vasopressors. We choose boluses of 75 
µg of phenylephrine and 7.5 mg of ephedrine because these are considered as standard doses 
commonly used in our institution. Whether lower or higher doses of phenylephrine and/or ephedrine 
would act similarly on SBF is unknown. The primary goal of vasopressors administration in our study 
was to counteract the hypotension induced by SA, not to establish a dose-response curve. 
Since we did not have any previous data on the SBF variations induced by phenylephrine and 
ephedrine, we could not calculate an appropriate sample size for each patient group. According to the 
large inter-individual SBF differences (see Table 2 and 3) measured by the Laser Doppler technique 
during a surgical procedure, ten patients per group were probably not sufficient to reach statistical 
significance. Another limitation of this investigation is a lack of simultaneous measurement of 
muscular blood flow. 
In conclusion, our study strongly suggests that an i.v. bolus of phenylephrine increase the SBF while 
ephedrine decreases SBF. These findings could be explained by the distribution of the alpha-
adrenoreceptor subtypes, and their relative predominance, among veins and different size of arteries 
in the subcutaneous tissue and in the skin. Further studies are needed for a better understanding of 
the physiology of SBF regulation under anaesthesia, as well as of the perfusion of other organs 
(placenta, kidney), in order to determine the most suitable vasopressor for clinical practice. 
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Table 1 : Patient characteristics and dermatomal sensory levels after spinal anaesthesia. 
Phen le hrine n = 10 
Sex: M/F NS 
NS 
NS 
NS 
Dermatomal 
senso level T7 T3-T10 NS 
. Datas are mean (SD), except dermatomal sensory level expressed as median and range. 
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Table 2 : Heart rate (HR), mean arterial pressure (MAP), mean skin blood flow (MSBF), conductance 
and variation of perfusion before and 20 minutes after spinal anaesthesia (SA) expressed in 
mean value (SD) 
HR (bpm) MAP (mmHg) MSBF (PU) Conductance f.. 
(PU mmHg-1) Perfusion 
before 1 Twenty before 1 Twenty be fore 1 Twenty before Twenty. (%) 
SA minutes SA minutes SA 1 minutes SA minutes 
i after SA after SA i after after SA 
1 1 SA 
! UL 1 UL UL UL UL 
130(7 4) 265(257) 1.31(0.84) 3.19(3.24) +105 
Phenylephrine 68(8) 73(9) 102(13) 87(10) * (150) 
n=lO LL LL LL LL LL 
1 
113 (61) 186 (77) . 1.15(0.71) 2.21(1.05) +75 
' (55) 
: UL 1 UL UL UL UL 
151(97) 1 207(204) 1.56(0.96) 2.33(2.28) +34 
Ephedrine 67(11) 64(11) 95(11) 84(12) * (74) 
n=lO LL 1 LL LL LL LL 
1 
100(79) 168(140) 1.07(0.86) 2.03{1.65) +78 
1 (56) 
* p <0.05 when compared to MAP before SA. UL= upper limb; LL= lower limb. 
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Table 3 : Heart rate (HR), mean arterial pressure (MAP), mean skin blood flow (MSBF), conductance 
and variation of perfusion prier and after administration of vasopressor (VP) expressed in 
mean value (SD) 
HR (bpm) MAP (mmHg) MSBF (PU) Conductance 6 
(PU mmHg-1) Perfusion 
before 1 after. before 
1 
after before 1 after before 1 after VP (%) 
VP 1 VP VP ! VP VP ; VP VP ; 
1 193(10) * 
UL 1 UL UL 1 UL UL Phenylephrine 73(9) 65(13) 86(11) 292(280) 358(286) 3.61(3.79) 3.96(3.20) +44 (79). 
n=10 
1 
LL 1 LL LL 1 LL LL 
1 180(73) 246(133) 2.16(1.00) 2.74(1.71) +34 (24) 
1 
UL 1 UL UL 1 UL UL 
Ephedrine 
1 
78(12) 248(232) 207(209) 3.08(2.73) 1 2.14(2.16) 
-16 (15) § 
n=10 60(8) 61(9) 94(13) * LL LL LL 1 LL LL 
162(114) 122(77) 2.16(1.58) 1.30(0.78) 
-22(11)# 
* p < 0.05 when compared to MAP before VP. § p < 0.05 when compared to 6 Perfusion at the upper 
limb after Phenylephrine. # p < 0.05 when compared to 6 Perfusion at the lower limb after 
Phenylephrine. UL= upper limb; LL= lower limb. 
- 13 -
Figure 1 : Mean arterial pressure (X (SD)) before SA, before vasopressor (VP) and after VP, with 
significant P values. 
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Figure 2 : Individual and mean value (X (SD)) of skin perfusion variation after bolus administration of 
ephedrine or phenylephrine. 
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